FDA Issues Guidance For Researchers Working With Cannabis
Law360 (July 21, 2020, 6:10 PM EDT) -- The U.S. Food and Drug Administration on Tuesday released draft guidance on best practices for investigating medical uses of cannabis, providing a new rubric for how to measure the THC concentration in solutions developed for potential drug treatments.
The guidance acknowledges that the legal definition of hemp — which is based on having less than 0.3% THC on a dry-weight basis — has limited utility once the cannabinoid compounds have been extracted from the plant and processed into intermediates and finished products.
"We note that intermediates or drug products that contain greater than 0.3 percent delta-9 THC by dry weight, even...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!